The Pacific Tower, formerly the Pacific Medical Center, is a 16-story building at 1200 12th Avenue South on Beacon Hill in Seattle, Washington, United States. It was completed in 1932 and opened the following year as a U.S. Public Health Service facility.

During the past decade, Pacific Medical Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 15 clinical trials were completed, i.e. on average, 1500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Medical Center" are "Breast Cancer" (4 trials), "Prostate Cancer" (4 trials), "Alzheimer's Disease" (3 trials), "Pain" (3 trials) and "Back Pain" (2 trials). Many other conditions were trialed in "Pacific Medical Center" in a lesser frequency.

Most popular intervention types in "Pacific Medical Center" are "Drug" (14 trials), "Other" (7 trials), "Procedure" (3 trials), "Device" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (7 trials), "docetaxel" (3 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "Eslicarbazepine acetate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Medical Center" are 13 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Pacific Medical Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Pacific Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".